Kimberly DeLong
Kimberly DeLong is a government contact at FDA Office Of Acq Grant Svcs. Kimberly is associated with 15 contracts. FDA Office Of Acq Grant Svcs has $437,256,220 in total awards. Activity spans Research and Development in Biotechnology (except Nanobiotechnology), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and All Other Professional, Scientific, and Technical Services.
Person Profile
Contracting officer information and contact details
Kimberly DeLong
Phone
+1 (555) 000-0000Agency
FDA Office Of Acq Grant Svcs
Code: 75F401
Department Of Health And Human Services (hhs) › Food And Drug Administration
Last seen
Mar 30, 2025
Most recent solicitation activity
Contracting Officer Overview
Industry focus, set-aside activity, and contract history for this federal contracting professional.
AI Professional Profile
Kimberly DeLong supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities that advance regulatory science and sustain scientific infrastructure. She manages a diverse portfolio of contracts focused on research and develo...
Kimberly DeLong supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities that advance regulatory science and sustain scientific infrastructure. She manages a diverse portfolio of contracts focused on research and development services, analytical instrumentation, and specialized laboratory support essential to the FDA’s mandate of ensuring drug safety, efficacy, and medical device security. Her work centers on acquiring high-precision technical services that enable the agency’s scientific evaluations and public health oversight, often involving complex, compliance-driven requirements under FAR and agency-specific regulations. DeLong maintains consistent procurement relationships with key contractors including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc, and Progenics Pharmaceuticals Inc, reflecting a preference for specialized firms with deep expertise in preclinical research, toxicology, and pharmaceutical development. These partnerships are typically non-competitive or competitively awarded under general services contracts, emphasizing technical capability, regulatory familiarity, and quality assurance in support of FDA’s scientific review processes. Her contracting patterns reflect a reliance on niche vendors with proven track records in delivering scientifically rigorous, audit-ready deliverables. Her procurement strategy prioritizes open competition, with approximately 90% of awards issued without set-aside restrictions, indicating a strong emphasis on technical merit and capability over socioeconomic preferences. Nevertheless, she consistently reserves 10% of opportunities for total small business set-asides under FAR 19.5, demonstrating a measured but intentional commitment to fostering small business participation within the specialized scientific services sector. DeLong’s primary procurement focus lies in NAICS 541714 (Biotechnology R&D) and 541715 (Life Sciences R&D), with additional activity in professional scientific services and pharmaceutical wholesale. She regularly acquires services related to clinical trial support, laboratory analysis, bioanalytical testing, and computational research tools, underscoring her expertise in the technical domains of regulatory science, pharmacology, and biomedical innovation.
Key Metrics
Total Contracts
15
Associated contracts
Industries
5
NAICS categories
Set-Aside Programs
1
Program types
Set-Aside Share
6.7%
Small-business awards
Procurement Analytics
Where this contracting officer directs award activity across FDA Office Of Acq Grant Svcs, by industry and small-business set-aside program.
Spending Trends
Spending Trends
Coming Soon
Works with
2 contracting officers at FDA Office Of Acq Grant Svcs
Recent Solicitations
Opportunities Kimberly DeLong is the point of contact for
SAM · FY22_BAA_AwardsFY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory ScienceFDA Office Of Acq Grant SvcsSAM · FDA-22-1255259Exosome mi RNA Profiling, Sequencing, and Analysis Service ContractFDA Office Of Acq Grant SvcsSAM · FDA-RFP-1252660Sole Source- Yuma Valley Leafy Greens Production Area Environmental Surveillance for Bacterial Foodborne PathogensFDA Office Of Acq Grant SvcsSAM · FDA-RFP-1251666Standards Development for Regenerative Medicine TherapiesFDA Office Of Acq Grant SvcsSAM · ALLAWARDSFY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory ScienceFDA Office Of Acq Grant SvcsSAM · FDA-NOI-1243522ToxIC Registry Online Access/ COVID-19 Sub-RegistriesFDA Office Of Acq Grant SvcsSAM · FDA-NOI-1243229Data Resource for Post-marketing Surveillance of Nonmedical Use of Pharmaceuticals and Use of Illicit Drug SubstancesFDA Office Of Acq Grant SvcsSAM · FDA-NOI-1239473Stability Studies of Reference Virus StocksFDA Office Of Acq Grant SvcsSAM · FDABAA-21-00123FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory ScienceFDA Office Of Acq Grant SvcsSAM · FDA-SSN-1238675Establishment of a Biologics Ordering Vehicle for CDERFDA Office Of Acq Grant SvcsReach the people behind FDA Office Of Acq Grant Svcs awards
Know who buys, what they buy, and when they buy it again
Contract history and award activity for Kimberly DeLong
Contact details and the offices each officer buys for
AI-powered matching between their requirements and your capabilities
Automated alerts when they post a new opportunity
Join 750+ contractors already using CLEATUS